We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

213 hedge funds and large institutions have $3.63B invested in NPS PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 68 increasing their positions, 83 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 28

60% more call options, than puts

Call options by funds: $104M | Put options by funds: $64.9M

39% more capital invested

Capital invested by funds: $2.61B → $3.63B (+$1.02B)

7% more funds holding

Funds holding: 200 → 213 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 83

Holders
213
Holders Change
+13
Holders Change %
+6.5%
% of All Funds
5.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
45
Increased
68
Reduced
83
Closed
28
Calls
$104M
Puts
$64.9M
Net Calls
+$38.7M
Net Calls Change
+$41.2M

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$70.9M
2
Goldman Sachs
Goldman Sachs
New York
+$25.4M
3
FCE
Fiera Capital (Europe)
Cayman Islands
+$12.6M
4
TCM
Tekla Capital Management
Massachusetts
+$11.6M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$29.9M
2
Millennium Management
Millennium Management
New York
-$19.3M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$17.9M
4
VAM
Visium Asset Management
New York
-$17M
5
PAI
Palo Alto Investors
California
-$15.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
151
Neuberger Berman Group
New York
$520K +$435K +14,558 New
CCMH
152
Cornerstone Capital Management Holdings
New York
$515K +$38.8K +1,300 +10%
TC
153
TFS Capital
Pennsylvania
$497K +$415K +13,902 New
FIM
154
Freedom Investment Management
Connecticut
$487K +$406K +13,608 New
CAN
155
Cetera Advisor Networks
California
$483K +$75.4K +2,525 +23%
LCM
156
Laurion Capital Management
New York
$469K +$391K +13,100 New
Stifel Financial
157
Stifel Financial
Missouri
$442K +$368K +12,337 New
SC
158
Scholtz & Company
Connecticut
$395K -$625K -20,940 -65%
FMT
159
First Mercantile Trust
Tennessee
$394K +$38.5K +1,290 +13%
ST
160
Spot Trading
Illinois
$390K +$326K +10,910 New
RJA
161
Raymond James & Associates
Florida
$382K -$11.3K -380 -3%
WS
162
Wedbush Securities
California
$382K +$319K +10,690 New
Tudor Investment Corp
163
Tudor Investment Corp
Connecticut
$358K +$48.6K +1,628 +19%
AB
164
Amalgamated Bank
New York
$349K +$567 +19 +0.2%
AIP
165
Ameritas Investment Partners
Nebraska
$341K – – –
Canada Life
166
Canada Life
Manitoba, Canada
$335K – – –
Fisher Asset Management
167
Fisher Asset Management
Washington
$334K +$279K +9,350 New
M&T Bank
168
M&T Bank
New York
$332K -$99.8K -3,343 -26%
RIM
169
Regent Investment Management
Kentucky
$290K -$65.7K -2,200 -21%
ACP
170
Acuta Capital Partners
California
$286K +$239K +8,000 New
BA
171
Boston Advisors
Massachusetts
$281K – – –
NIT
172
NumerixS Investment Technologies
British Columbia, Canada
$268K +$224K +7,500 New
PI
173
Placemark Investments
Illinois
$265K -$17.2K -576 -7%
BAAM
174
Baker Avenue Asset Management
California
$263K -$367K -12,310 -63%
CSS
175
Cubist Systematic Strategies
Connecticut
$263K -$67.4K -2,258 -24%
5 6
7
8 9

NPSP Hedge Fund Activity: Q4 2014 in Review

213 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2014, worth a combined $3.63B — up 39% from $2.61B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new NPSP positions and 28 closed out — a net gain of 17 holders — while 68 added to existing stakes and 83 trimmed.

The largest buyer was First Trust Advisors, opening a new position worth an estimated $70.9M. The largest seller was Wells Fargo, cutting an estimated $29.9M.

  • 213 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2014, up from 200 in Q3 2014.
  • Funds reported $3.63B of NPS PHARMACEUTICALS INC stock for Q4 2014, up 39% quarter-over-quarter.
  • 45 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2014 and 28 closed out, a net change of +17 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q4 2014 was First Trust Advisors, an estimated $70.9M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q4 2014 was Wells Fargo, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2014.